Literature DB >> 31628657

Structural Insight of Gasdermin Family Driving Pyroptotic Cell Death.

Jianbin Ruan1.   

Abstract

Gasdermin is a recently identified family of pore-forming proteins consisting of Gasdermin A (pan class="Gene">GSDMA), Gasdermin B (GSDMB), Gasdermin C (GSDMC), Gasdermin D (GSDMD), Gasdermin E (GSDME), and DFNB59. Gasdermin D (GSDMD) is a downstream effector of inflammasomes, which are supramolecular complexes that activate inflammatory caspases (-1, -4, and -5 in human and -1 and -11 in mouse). GSDMD contains a functionally important N-terminal domain (GSDMD-N), a C-terminal domain, and a linker in between that is recognized and cleaved by the activated inflammatory caspases. Upon cleavage, the GSDMD-N fragments translocate on the membrane and oligomerize to form membrane-embedded pores after specifically binding to acidic lipids such as phosphatidylinositol phosphates (PIPs), phosphatidic acid (PA), phosphatidylserine (PS), and cardiolipin. The pore exhibits strong membrane-disrupting cytotoxicity in mammalian cells by disrupting the osmotic potential and also serves as a gate for extracellular release of mature IL-1β and IL-18 during pyroptosis. In this chapter, we review our current understanding of GSDM proteins in physiological and pathological cell death, with more focused discussions on its structural basis for GSDM activation and pore formation.

Entities:  

Keywords:  Gasdermin; Inflammasomes; Inflammatory caspases; Innate immunity; Pore-forming protein; Pyroptosis

Mesh:

Substances:

Year:  2019        PMID: 31628657     DOI: 10.1007/978-981-13-9367-9_9

Source DB:  PubMed          Journal:  Adv Exp Med Biol        ISSN: 0065-2598            Impact factor:   2.622


  15 in total

Review 1.  Outer Membrane Lipid Secretion and the Innate Immune Response to Gram-Negative Bacteria.

Authors:  Nicole P Giordano; Melina B Cian; Zachary D Dalebroux
Journal:  Infect Immun       Date:  2020-06-22       Impact factor: 3.441

Review 2.  Mechanistic Insights into Gasdermin Pore Formation and Regulation in Pyroptosis.

Authors:  Chengliang Wang; Jianbin Ruan
Journal:  J Mol Biol       Date:  2021-10-08       Impact factor: 5.469

Review 3.  Role of GSDMB in Pyroptosis and Cancer.

Authors:  Lisha Li; Yanjing Li; Yuxian Bai
Journal:  Cancer Manag Res       Date:  2020-04-30       Impact factor: 3.989

4.  JQ1 as a BRD4 Inhibitor Blocks Inflammatory Pyroptosis-Related Acute Colon Injury Induced by LPS.

Authors:  Ling Chen; Xiaolin Zhong; Wenyu Cao; Mingli Mao; Wei Li; Hui Yang; Menglin Li; Mengmeng Shi; Yuan Zhang; Yincheng Deng; Xuyu Zu; Jianghua Liu
Journal:  Front Immunol       Date:  2021-02-18       Impact factor: 7.561

Review 5.  Role of pyroptosis in spinal cord injury and its therapeutic implications.

Authors:  Abdullah Al Mamun; Yanqing Wu; Ilma Monalisa; Chang Jia; Kailiang Zhou; Fahad Munir; Jian Xiao
Journal:  J Adv Res       Date:  2020-08-18       Impact factor: 10.479

Review 6.  Pyroptosis: a new paradigm of cell death for fighting against cancer.

Authors:  Yixin Tan; Quanzhu Chen; Xiaoling Li; Zhaoyang Zeng; Wei Xiong; Guiyuan Li; Xiayu Li; Jianbo Yang; Bo Xiang; Mei Yi
Journal:  J Exp Clin Cancer Res       Date:  2021-05-03

7.  Integrated analysis of expression, prognostic value and immune infiltration of GSDMs in hepatocellular carcinoma.

Authors:  Kuan Hu; Zhijie Xu; Lei Yao; Yuanliang Yan; Lei Zhou; Juanni Li
Journal:  Aging (Albany NY)       Date:  2021-11-03       Impact factor: 5.682

8.  High Expression of GSDMC Is Associated with Poor Survival in Kidney Clear Cell Cancer.

Authors:  Yun-Qian Cui; Fei Meng; Wen-Li Zhan; Zhou-Tong Dai; Xinghua Liao
Journal:  Biomed Res Int       Date:  2021-11-05       Impact factor: 3.411

Review 9.  The Versatile Gasdermin Family: Their Function and Roles in Diseases.

Authors:  Ju Zou; Yixiang Zheng; Yan Huang; Daolin Tang; Rui Kang; Ruochan Chen
Journal:  Front Immunol       Date:  2021-11-11       Impact factor: 7.561

Review 10.  GSDMD-mediated pyroptosis: a critical mechanism of diabetic nephropathy.

Authors:  Yi Zuo; Li Chen; Huiping Gu; Xiaoyun He; Zhen Ye; Zhao Wang; Qixiang Shao; Caiping Xue
Journal:  Expert Rev Mol Med       Date:  2021-12-27       Impact factor: 5.600

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.